- You can view the full GlaxoSmithKline Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Global stocks tumbled, with markets in Asia losing all of their year-to-date gains, as China declared it's "not afraid" of an escalating trade war with the United States following President Trump's decision to target $50 billion in China-made goods.
The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.
With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.